ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
102,708.80
0.63%
S&P 500
6,012.28
-1.46%
Dow Jones
44,713.58
0.65%
US Dollar vs Yen
155.907
0.62%
Brent Oil
76.895
0.82%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) ニュース

PRTC

PureTech Health (PRTC)

PureTech Health PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PRTC
日付受信時刻ニュースソース見出しコード企業名
2025/01/2716 : 00Business WirePureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature MedicineNASDAQ:PRTCPureTech Health PLC
2025/01/0921 : 00Business WirePureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)NASDAQ:PRTCPureTech Health PLC
2025/01/0821 : 00Business WirePureTech to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
2025/01/0616 : 00Business WirePureTech Appoints UBS as UK Corporate BrokerNASDAQ:PRTCPureTech Health PLC
2024/12/1616 : 00Business WirePureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b TrialNASDAQ:PRTCPureTech Health PLC
2024/12/1121 : 05Business WirePureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024NASDAQ:PRTCPureTech Health PLC
2024/12/0916 : 00Business WirePureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual MeetingNASDAQ:PRTCPureTech Health PLC
2024/11/2021 : 05Business WirePureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
2024/11/0521 : 05Business WirePureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
2024/10/3020 : 00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
2024/10/2115 : 00Business WirePureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing RoundNASDAQ:PRTCPureTech Health PLC
2024/10/0915 : 00Business WirePureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
2024/10/0120 : 00Business WirePureTech to Present at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
2024/09/2715 : 00Business WirePureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in AdultsNASDAQ:PRTCPureTech Health PLC
2024/09/0615 : 00Business WirePureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:PRTCPureTech Health PLC
2024/08/2905 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
2024/08/2820 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
2024/08/2815 : 01Business WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
2024/08/2305 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
2024/08/2215 : 00Business WirePureTech Appoints Michele Holcomb, PhD, to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
2024/08/2115 : 00Business WirePureTech Health: Notice of Half-Yearly ResultsNASDAQ:PRTCPureTech Health PLC
2024/08/1320 : 05Business WirePureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
2024/07/2321 : 26Business WirePureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of CommercialNASDAQ:PRTCPureTech Health PLC
2024/06/2501 : 00Business WirePureTech Health: Completion of Tender Offer & Total Voting RightsNASDAQ:PRTCPureTech Health PLC
2024/06/2415 : 00Business WirePureTech Health: Results of the Tender OfferNASDAQ:PRTCPureTech Health PLC
2024/06/2015 : 00Business WirePureTech Announces Change of Board RoleNASDAQ:PRTCPureTech Health PLC
2024/06/1820 : 05Business WirePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamNASDAQ:PRTCPureTech Health PLC
2024/06/1405 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
2024/06/1402 : 15Business WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
2024/06/0705 : 39Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

最近閲覧した銘柄

NYSE
NKE
Nike
AMEX
SPY
SPDR S&P 500
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
NYSE
BAC
Bank of America
COIN
AVAXUSD
Avalanche
NYSE
CVX
Chevron
CCOM
US30
US 30
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLV
Health Care Select Sector
FX
USDGBP
US Dollar vs Sterling
NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有